The Transplant Cohort of the German Center for Infection Research
Launched by TECHNICAL UNIVERSITY OF MUNICH · Apr 3, 2024
Trial Information
Current as of July 04, 2025
Recruiting
Keywords
ClinConnect Summary
The Transplant Cohort of the German Center for Infection Research is a study that aims to understand how different factors affect organ health and the risk of infections in patients who have received transplants. Researchers are collecting medical information and biological samples from transplant patients across Germany to help them learn more about how immunosuppression (medications that help prevent organ rejection) can impact organ function and susceptibility to infections. This knowledge could lead to better care for transplant patients in the future.
To participate in this study, individuals must have received a transplant of a kidney, pancreas, liver, heart, or stem cells and be willing to give their consent. The study is open to all ages and genders. Participants can expect to contribute their medical data and samples, which will be used for research purposes. This is an important opportunity that may help improve outcomes for future transplant patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Consent
- • undergone transplantation of kidney, pancreas, liver, heart or stem cells
- Exclusion Criteria:
- • No consent
About Technical University Of Munich
The Technical University of Munich (TUM) is a leading research institution in Germany, renowned for its commitment to excellence in education, innovation, and technology transfer. With a strong emphasis on interdisciplinary collaboration, TUM fosters advancements in various fields, including medicine and life sciences. The university actively engages in clinical research, aiming to translate scientific discoveries into practical applications that improve patient outcomes. Through its state-of-the-art facilities and a network of partnerships with hospitals and industry, TUM is dedicated to conducting rigorous clinical trials that adhere to the highest ethical standards and contribute significantly to the advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
München, , Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported